Journal News

Fat cells are a culprit in osteoporosis

Oluwadamilola “Dami” Oke
April 11, 2025

Approximately 10 million Americans have osteoporosis, also known as a silent disease due to symptoms that go unnoticed until a fracture occurs. Scientists are focused on understanding the mechanisms that contribute to the loss of bone strength, as well as developing therapies for prevention and treatment.

Illustration of adipocyte fat cells.
Illustration of adipocyte fat cells.

Weibo Hunag, Feng Hua and Tong Suand a team in China published an article in the Journal of Lipid Research. They investigated the relationship between bone marrow adipocytes, or BMAds, and osteoblast bone building cells. BMAds are fat cells that reside in the bone marrow, and contribute to 10% of the total body fat and occupy 50–70% of the marrow cavity space. Their abundance has been associated with aging, postmenopausal period, obesity, radiotherapy and chemotherapy and glucocorticoid treatments.

The researchers treated bone marrow osteoblast cultures with adipocytes and observed that the adipocytes transferred lipid droplets to the osteoblasts. RNA sequencing and Western blot showed that the lipid droplet–filled osteoblasts downregulated osteopontin, a major bone-forming protein, and other osteogenic proteins. Furthermore, the lipids seemed to upregulate the ferroptosis pathway in the osteoblasts, inducing cell death, and it decreased oxidative phosphorylation, which generates cellular energy. When the researchers treated the osteoblasts with ferroptosis inhibitors, they found that impediments to the osteoblast cells were reversed. 

This work shows the ferroptosis pathway and proteins such as ABHD5 as important targets for the development of effective treatments and prevention therapies for osteoporosis. Looking ahead, the researchers will conduct further investigations into the activation mechanisms of these pathways to provide a solid foundation for clinical translation.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Oluwadamilola “Dami” Oke

Oluwadamilola “Dami” Oke is a Ph.D. candidate of biomedical engineering at the George Washington University with an interest in communication and outreach for science advancement. She is an ASBMB Today contributing writer.

Related articles

Meet Shannon Reilly
Elisabeth Adkins Marnik
From the Journals: JLR
Vanshika Patel
Meet Robert Helsley
Christopher Radka

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Computational tool helps scientists create novel bug sprays
Journal News

Computational tool helps scientists create novel bug sprays

May 20, 2025

Rapid discovery of mosquito repellent compounds is enabled through a novel screening platform that combines both computational modeling and functional screening.

Meet Lan Huang
Interview

Meet Lan Huang

May 19, 2025

Molecular & Cellular Proteomics associate editor uses crosslinking mass spec to study protein–protein interactions to find novel therapeutics.

Influenza gets help from gum disease bacteria
Journal News

Influenza gets help from gum disease bacteria

May 15, 2025

Scientists discover that a protease from Porphyromonas gingivalis enhances viral spread. Read more about this recent Journal of Biological Chemistry paper.

How bacteria fight back against promising antimicrobial peptide
Journal News

How bacteria fight back against promising antimicrobial peptide

May 15, 2025

Researchers find a mutation in E. coli that reduces its susceptibility to a potential novel antibiotic. Read more about this recent Journal of Biological Chemistry paper.

New clues reveal how cells respond to stress
Journal News

New clues reveal how cells respond to stress

May 15, 2025

Redox signaling protein may help regulate inflammasome and innate immune activation. Read more about this recent Journal of Biological Chemistry paper.

Innovative platform empowers scientists to transform venoms into therapeutics
Journal News

Innovative platform empowers scientists to transform venoms into therapeutics

May 13, 2025

Scientists combine phage display and a “metavenome” library to discover new drugs that bind clinically relevant human cell receptors. Read about this recent Molecular & Cellular Proteomics paper.